090430.KS
Amorepacific Corporation [090430.KS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
090430.KS Stock Summary
Top 10 Correlated Stocks
090430.KS
In the News
090430.KS Financial details
Company Rating
Buy
Market Cap
9273.33B
Income
68.37B
Revenue
4371.91B
Book val./share
69898.29
Cash/share
-
Dividend
-
Dividend %
-
Employees
4.8K
Optionable
No
Shortable
Yes
Earnings
07 Feb 2023
P/E
149.28
Forward P/E
-
PEG
15.9
P/S
2.33
P/B
2.12
P/C
-
P/FCF
54.39
Quick Ratio
-
Current Ratio
2.17
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
992.75
EPS next Y
-
EPS next Q
-
EPS this Y
552.78%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-10.16%
Revenue last 5Y
-1.04%
Revenue Q/Q
-0.98%
EPS Q/Q
-178.63%
-
-
-
-
SMA20
6.31%
SMA50
21.97%
SMA100
22.26%
Inst Own
-
Inst Trans
-
ROA
1%
ROE
1%
ROC
0.04%
Gross Margin
68%
Oper. Margin
4%
Profit Margin
2%
Payout
-
Shs Outstand
58.44M
Shs Float
38.84M
-
-
-
-
Target Price
-
52W Range
86800.0-191500.0
52W High
-22.61%
52W Low
+70.74%
RSI
56
Rel Volume
0.67
Avg Volume
301.45K
Volume
200.6K
Perf Week
3.35%
Perf Month
9.78%
Perf Quarter
16.24%
Perf Half Y
14.88%
-
-
-
-
Beta
1.17487
-
-
Volatility
2981.58%, 6973.05%
Prev Close
-0.94%
Price
148200
Change
-1.66%
090430.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
| Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 87.7K | 90.33K | 96.07K | 76.48K | 83.92K | |
| Net income per share | 6.74K | 5.69K | 4.11K | 606.26 | 3.34K | |
| Operating cash flow per share | 8.77K | 11.07K | 12.37K | 9.57K | 11.93K | |
| Free cash flow per share | -5.11K | 3.25K | 7.52K | 5.86K | 9.84K | |
| Cash per share | 11.4K | 13.36K | 15.18K | 17.57K | 19.51K | |
| Book value per share | 71.1K | 75.69K | 77.29K | 77.1K | 82.16K | |
| Tangible book value per share | 67.36K | 71.75K | 73.56K | 73.44K | 78.39K | |
| Share holders equity per share | 71.1K | 75.69K | 77.29K | 77.1K | 82.16K | |
| Interest debt per share | 2.27K | 2.03K | 10.07K | 7.55K | 6.93K | |
| Market cap | 18082.68B | 10428.94B | 11268.09B | 12922.72B | 8982.16B | |
| Enterprise value | 17608B | 9809.57B | 11159.37B | 12549.76B | 8834.57B | |
| P/E ratio | 45.89 | 31.39 | 47.19 | 367.83 | 46.38 | |
| Price to sales ratio | 3.53 | 1.98 | 2.02 | 2.92 | 1.85 | |
| POCF ratio | 35.28 | 16.13 | 15.69 | 23.31 | 12.99 | |
| PFCF ratio | -60.52 | 54.9 | 25.79 | 38.08 | 15.75 | |
| P/B Ratio | 4.35 | 2.36 | 2.51 | 2.89 | 1.89 | |
| PTB ratio | 4.35 | 2.36 | 2.51 | 2.89 | 1.89 | |
| EV to sales | 3.44 | 1.86 | 2 | 2.83 | 1.82 | |
| Enterprise value over EBITDA | 22.29 | 13.65 | 12.52 | 24.41 | 12.92 | |
| EV to operating cash flow | 34.35 | 15.17 | 15.54 | 22.64 | 12.78 | |
| EV to free cash flow | -58.93 | 51.64 | 25.54 | 36.98 | 15.49 | |
| Earnings yield | 0.02 | 0.03 | 0.02 | 0 | 0.02 | |
| Free cash flow yield | -0.02 | 0.02 | 0.04 | 0.03 | 0.06 | |
| Debt to equity | 0.01 | 0.01 | 0.06 | 0.03 | 0.02 | |
| Debt to assets | 0.22 | 0.17 | 0.25 | 0.22 | 0.22 | |
| Net debt to EBITDA | -0.6 | -0.86 | -0.12 | -0.73 | -0.22 | |
| Current ratio | 1.6 | 2.05 | 1.69 | 1.89 | 1.74 | |
| Interest coverage | 193.63 | 206.42 | 21.42 | 8.4 | 30.09 | |
| Income quality | 1.3 | 1.95 | 3.01 | 15.78 | 3.57 | |
| Dividend Yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Payout ratio | 0.28 | 0.27 | 0.34 | 1.95 | 0.28 | |
| Sales general and administrative to revenue | 0.08 | 0.08 | 0.05 | 0.04 | 0.04 | |
| Research and developement to revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Intangibles to total assets | 0.04 | 0.05 | 0.04 | 0.04 | 0.03 | |
| Capex to operating cash flow | -1.58 | -0.71 | -0.39 | -0.39 | -0.18 | |
| Capex to revenue | -0.16 | -0.09 | -0.05 | -0.05 | -0.02 | |
| Capex to depreciation | -3.63 | -1.72 | -0.58 | -0.47 | -0.33 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 103.86K | 98.4K | 84.56K | 32.43K | 78.6K | |
| ROIC | 0.14 | 0.1 | 0.09 | 0.03 | 0.07 | |
| Return on tangible assets | 0.08 | 0.06 | 0.04 | 0.01 | 0.03 | |
| Graham Net | -5.93K | 984.96 | -6.58K | -210.62 | 78.62 | |
| Working capital | 631.03B | 804.02B | 736.5B | 859.79B | 861.04B | |
| Tangible asset value | 3935.64B | 4192.3B | 4272.32B | 4255.62B | 4542.62B | |
| Net current asset value | 477.17B | 642.52B | 312.9B | 588.21B | 646.11B | |
| Invested capital | 0.03 | 0.03 | 0.13 | 0.09 | 0.08 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 124.85B | 114.73B | 145.04B | 117.62B | 120.51B | |
| Average inventory | 394.62B | 408.89B | 433.54B | 414.48B | 453.85B | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 34.94 | 28.45 | 41.95 | 33.93 | 33.06 | |
| Days of inventory on hand | 99.14 | 102.59 | 110.09 | 119.56 | 132.12 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 10.45 | 12.83 | 8.7 | 10.76 | 11.04 | |
| Inventory turnover | 3.68 | 3.56 | 3.32 | 3.05 | 2.76 | |
| ROE | 0.09 | 0.08 | 0.05 | 0.01 | 0.04 | |
| Capex per share | -13.89K | -7.82K | -4.85K | -3.71K | -2.09K |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
| Metric | History | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 |
|---|---|---|---|---|---|---|
| Revenue per share | 16.1K | 19.24K | 16.92K | 13.73K | 13.6K | |
| Net income per share | 579 | -616.65 | 1.7K | -447.01 | 351.49 | |
| Operating cash flow per share | 1.49K | 4.62K | -778.62 | -135.43 | 780.28 | |
| Free cash flow per share | 1.03K | 4.18K | -1.24K | -484.03 | 266.37 | |
| Cash per share | 15.82K | 16.41K | 0 | 0 | 0 | |
| Book value per share | 70.41K | 69.13K | 69.91K | 69.45K | 69.9K | |
| Tangible book value per share | 67.4K | 65.96K | 69.7K | 69.13K | 69.53K | |
| Share holders equity per share | 70.41K | 69.13K | 69.91K | 69.45K | 69.9K | |
| Interest debt per share | 5.9K | 5.66K | -44.58 | -94.41 | -47.55 | |
| Market cap | 12293.35B | 11501.34B | 11019.25B | 8953.14B | 7024.77B | |
| Enterprise value | 12127.91B | 11353.75B | 11019.25B | 8953.14B | 7024.77B | |
| P/E ratio | 77.07 | -67.7 | 23.46 | -72.71 | 72.55 | |
| Price to sales ratio | 11.09 | 8.68 | 9.46 | 9.47 | 7.5 | |
| POCF ratio | 119.87 | 36.15 | -205.49 | -959.92 | 130.72 | |
| PFCF ratio | 173.06 | 39.92 | -128.88 | -268.58 | 382.92 | |
| P/B Ratio | 2.54 | 2.42 | 2.29 | 1.87 | 1.46 | |
| PTB ratio | 2.54 | 2.42 | 2.29 | 1.87 | 1.46 | |
| EV to sales | 10.94 | 8.57 | 9.46 | 9.47 | 7.5 | |
| Enterprise value over EBITDA | 95.13 | 221.03 | 70.39 | -478.71 | 121.13 | |
| EV to operating cash flow | 118.26 | 35.69 | -205.49 | -959.92 | 130.72 | |
| EV to free cash flow | 170.73 | 39.4 | -128.88 | -268.58 | 382.92 | |
| Earnings yield | 0 | 0 | 0.01 | 0 | 0 | |
| Free cash flow yield | 0.01 | 0.03 | -0.01 | 0 | 0 | |
| Debt to equity | 0.02 | 0.02 | 0 | 0 | 0 | |
| Debt to assets | 0.21 | 0.22 | 0.2 | 0.19 | 0.18 | |
| Net debt to EBITDA | -1.3 | -2.87 | 0 | 0 | 0 | |
| Current ratio | 2.05 | 1.74 | 1.95 | 1.95 | 2.17 | |
| Interest coverage | 0 | 0 | -51.46 | 3 | -5.74 | |
| Income quality | 2.57 | -7.49 | -0.46 | 0.3 | 2.22 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.04 | 0.04 | 0.55 | 0.68 | 0.64 | |
| Research and developement to revenue | 0.02 | 0.02 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.03 | 0.03 | 0 | 0 | 0 | |
| Capex to operating cash flow | -0.31 | -0.09 | 0.59 | 2.57 | -0.66 | |
| Capex to revenue | -0.03 | -0.02 | -0.03 | -0.03 | -0.04 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | -0.48 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 30.29K | 30.97K | 51.79K | 26.43K | 23.51K | |
| ROIC | 0.01 | 0.01 | 0.03 | 0 | 0 | |
| Return on tangible assets | 0.01 | -0.01 | 0.02 | -0.01 | 0 | |
| Graham Net | 1.04K | 66.16 | -17.81K | -16.44K | -15.68K | |
| Working capital | 1098.85B | 861.04B | 962.97B | 903.15B | 1045.38B | |
| Tangible asset value | 4642.05B | 4542.62B | 0 | 0 | 0 | |
| Net current asset value | 868.32B | 646.11B | 753.78B | 719.08B | 861.7B | |
| Invested capital | 0.08 | 0.08 | 0 | 0 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 43 | 29.22 | 0 | 0 | 0 | |
| Days of inventory on hand | 149.95 | 116.78 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 2.09 | 3.08 | 0 | 0 | 0 | |
| Inventory turnover | 0.6 | 0.77 | 0 | 0 | 0 | |
| ROE | 0.01 | -0.01 | 0.02 | -0.01 | 0.01 | |
| Capex per share | -457.66 | -435.4 | -462.86 | -348.6 | -513.91 |
090430.KS Frequently Asked Questions
What is Amorepacific Corporation stock symbol ?
Amorepacific Corporation is a KR stock and trading under the symbol 090430.KS
What is Amorepacific Corporation stock quote today ?
Amorepacific Corporation stock price is $148200 today.
Is Amorepacific Corporation stock public?
Yes, Amorepacific Corporation is a publicly traded company.
Company Profile
- Volume Average 301.45K
- Market Capitalization 9273.33B
- Employee 4.8K
- CEO Mr. Kyung-Bae Suh
- Headquarters Seoul,KR
- IPO Date 2006-06-29
-
Website
https://www.amorepacific.com 
Amorepacific Corporation manufactures and sells beauty, household, and healthcare products worldwide. The company offers skincare products, cleansers, toners and fluids, moisturizers, eye care products, serums, masks, and special care and travel products. It provides anti-ageing, dryness, tone and texture, sun protection, and makeup products. The company was founded in 1945 and is based in Seoul, South Korea.
